These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38259291)

  • 1. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis.
    Dan L; Hao Y; Li J; Wang T; Zhao W; Wang H; Qiao L; Xie P
    Front Pharmacol; 2023; 14():1287750. PubMed ID: 38259291
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies.
    Hao Y; Li J; Yue S; Wang S; Hu S; Li B
    Front Pharmacol; 2022; 13():917375. PubMed ID: 35734409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis.
    Liu JY; Dai Y; He YX; Lin L
    Front Pharmacol; 2023; 14():1301102. PubMed ID: 38293672
    [No Abstract]   [Full Text] [Related]  

  • 4. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acupuncture on neuroinflammation in animal models of Alzheimer's disease: A preclinical systematic review and meta-analysis.
    Wu ZG; Huang YJ; Wang TY; Deng CY; Xu ZR; Tang CZ
    Front Aging Neurosci; 2023; 15():1110087. PubMed ID: 36936500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
    Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
    BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.
    Sadraie S; Kiasalari Z; Razavian M; Azimi S; Sedighnejad L; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
    Metab Brain Dis; 2019 Feb; 34(1):245-255. PubMed ID: 30456649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
    Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
    Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
    Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
    Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer's disease: A systematic review and meta-analysis.
    Du XY; Cao YS; Yang J; Guo LC; Zhang T; Yuan Q; Chen X; Hu LM
    Front Pharmacol; 2022; 13():956746. PubMed ID: 36120381
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.
    Akbar M; Shabbir A; Rehman K; Akash MSH; Shah MA
    J Food Biochem; 2021 Oct; 45(10):e13936. PubMed ID: 34523148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.
    Hu HC; Lei YH; Zhang WH; Luo XQ
    Front Pharmacol; 2022; 13():841818. PubMed ID: 35355720
    [No Abstract]   [Full Text] [Related]  

  • 14. Verum- versus Sham-Acupuncture on Alzheimer's Disease (AD) in Animal Models: A Preclinical Systematic Review and Meta-Analysis.
    Zhao FY; Fu QQ; Zheng Z; Lao LX; Song HL; Shi Z
    Biomed Res Int; 2020; 2020():5901573. PubMed ID: 32337259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine Reduces Aβ
    Wu Y; Chen Q; Wen B; Wu N; He B; Chen J
    Front Pharmacol; 2021; 12():640758. PubMed ID: 34349640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
    Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
    J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.
    Singh A; Dhaneshwar S; Mazumder A
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):182-190. PubMed ID: 34515019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galangin alleviates learning and memory impairments in APP/PS1 double- transgenic mice by regulating Akt/MEF2D/Beclin-1 signaling pathway].
    Huang LP; Zhong XQ; Zhou XY; Deng MQ; Wu MJ; Deng MZ
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2729-2737. PubMed ID: 35718493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action.
    Hu S; Wang J; Liu E; Zhang X; Xiang J; Li W; Wei P; Zeng J; Zhang Y; Ma X
    Pharmacol Res; 2022 Nov; 185():106481. PubMed ID: 36195307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.